By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore said today that with the completion of its purchase by Merck KGaA, it is delivering a notice to holders of its 3.75 percent Convertible Senior Notes due 2026 that the effective date of the Make-Whole Fundamental Change was July 14, when the deal was completed.

The purchase's completion also triggered an increase in the conversion rate "applicable to notes surrendered for conversion during the Make-Whole Conversion period," Millipore said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.